The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Source link
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Date:
More like thisRelated
Western Union Profit Falls as Immigration Policy Hurts Remittances
Western Union reported lower first-quarter profit and said that...
Fernando Mendoza: ‘Huge responsibility’ to be face of Raiders
Ryan McFaddenApr 24, 2026, 07:51 PM ETCloseRyan McFadden covers...
OpenAI CEO Sam Altman “deeply sorry” for failing to alert law enforcement to Canada school shooter’s ChatGPT account
OpenAI CEO Sam Altman has...
Final Gathering of Nations powwow creates lasting memories for children
SUPPLEMENTS, ILLEGAL DRUGS AND NEEDLES ARE NOT ALLOWED. THE...